Swiss National Bank’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,883
| Closed | -$241K | – | 2614 |
|
|
2023
Q3 | $241K | Sell |
4,883
-495
| -9% | -$24.5K | ﹤0.01% | 2596 |
|
|
2023
Q2 | $421K | Buy |
5,378
+1,004
| +23% | +$78.5K | ﹤0.01% | 2564 |
|
|
2023
Q1 | $396K | Sell |
4,374
-509
| -10% | -$46.1K | ﹤0.01% | 2573 |
|
|
2022
Q4 | $576K | Buy |
4,883
+126
| +3% | +$14.9K | ﹤0.01% | 2540 |
|
|
2022
Q3 | $863K | Buy |
4,757
+1,409
| +42% | +$256K | ﹤0.01% | 2405 |
|
|
2022
Q2 | $300K | Sell |
3,348
-339
| -9% | -$30.4K | ﹤0.01% | 2710 |
|
|
2022
Q1 | $572K | Buy |
3,687
+257
| +7% | +$39.9K | ﹤0.01% | 2571 |
|
|
2021
Q4 | $1.02M | Hold |
3,430
| – | – | ﹤0.01% | 2470 |
|
|
2021
Q3 | $1.98M | Hold |
3,430
| – | – | ﹤0.01% | 2057 |
|
|
2021
Q2 | $1.56M | Buy |
3,430
+2,152
| +168% | +$977K | ﹤0.01% | 2260 |
|
|
2021
Q1 | $688K | Hold |
1,278
| – | – | ﹤0.01% | 2422 |
|
|
2020
Q4 | $1.13M | Buy |
+1,278
| New | +$1.13M | ﹤0.01% | 2234 |
|